Antidepressant fluoxetine and its potential against colon tumors

被引：18

作者：

Stopper, Helga ^{[1
]}

Garcia, Sergio Britto ^{[2
]}

Waaga-Gasser, Ana Maria ^{[3
]}

Kannen, Vinicius ^{[1
]}

机构：

[1] Univ Wurzburg, Dept Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany

[2] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Pathol, BR-14040902 Ribeirao Preto, SP, Brazil

[3] Univ Wurzburg, Dept Surg Mol Oncol & Immunol 1, D-97078 Wurzburg, Germany

来源：

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY | 2014年 / 6卷 / 01期

基金：

巴西圣保罗研究基金会;

关键词：

Fluoxetine; Colon cancer; Cancer therapy; Tumor metabolism; SEROTONIN REUPTAKE INHIBITORS; SMOOTH-MUSCLE-CELLS; CANCER-ASSOCIATED FIBROBLASTS; ENDOTHELIAL PROGENITOR CELLS; OXIDATIVE STRESS; STEM-CELLS; SIGNALING PATHWAY; PERIPHERAL-BLOOD; DNA-SYNTHESIS; CARCINOMA;

D O I：

10.4251/wjgo.v6.i1.11

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Colon cancer is one of the most common tumors worldwide, with increasing incidence in developing countries. Patients treated with fluoxetine (FLX) have a reduced incidence of colon cancer, although there still remains great controversy about the nature of its effects. Here we explore the latest achievements related to FLX treatment and colon cancer. Moreover, we discuss new ideas about the mechanisms of the effects of FLX treatment in colon cancer. This leads to the hypothesis of FLX arresting colon tumor cells at the at G(1) cell-cycle phase through a control of the tumor-related energy generation machinery. We believe that the potential of FLX to act against tumor metabolism warrants further investigation. (C) 2014 Baishideng Publishing Group Co., Limited. All rights reserved.

引用

页码：11 / 21

页数：11

共 50 条

[31] Does estrogen enhance the antidepressant effects of fluoxetine?
Tam, LW
Parry, BL
JOURNAL OF AFFECTIVE DISORDERS, 2003, 77 (01) : 87 - 92
[32] STUDY ON PERFORMANCE AND ALCOHOL INTERACTION WITH THE ANTIDEPRESSANT FLUOXETINE
SCHAFFLER, K
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1989, 4 : 15 - 20
[33] Sleep deprivation hastens the antidepressant action of fluoxetine
Benedetti, F
Barbini, B
Lucca, A
Campori, E
Colombo, C
Smeraldi, E
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1997, 247 (02) : 100 - 103
[34] PATTERN-ANALYSIS OF ANTIDEPRESSANT RESPONSE TO FLUOXETINE
FIEVE, RR
GOODNICK, PJ
PESELOW, ED
BAROUCHE, F
SCHLEGEL, A
JOURNAL OF CLINICAL PSYCHIATRY, 1986, 47 (11) : 560 - 562
[35] QUANTIFICATION AND MECHANISM OF THE FLUOXETINE AND TRICYCLIC ANTIDEPRESSANT INTERACTION
BERGSTROM, RF
PEYTON, AL
LEMBERGER, L
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (03) : 239 - 248
[36] Lovastatin potentiates the antidepressant efficacy of fluoxetine in rats
Renshaw, Perry F.
Parsegian, Aram
Yang, C. Kevin
Novero, Aileen
Yoon, Sujung J.
Lyoo, In Kyoon
Cohen, Bruce M.
Carlezon, William A., Jr.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2009, 92 (01) : 88 - 92
[37] Gap junction is essential for the antidepressant effects of fluoxetine
Xia, Cong-Yuan
Zhang, Ning-Ning
Jiang, Hong
Lou, Yu-Xia
Ren, Qian
Zhang, Xiao-Ling
Yang, Peng-Fei
Shao, Qian-Hang
Zhu, Hao-Yu
Wan, Jiang-Fan
Zhang, Ya-Ni
Li, Fang-Fang
Yan, Xu
Chu, Shi-Feng
Zhang, Yi
Wang, Zhen-Zhen
Chen, Nai-Hong
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2023, 75 (05) : 686 - 692
[38] In vivo and in vitro estrogenic activity of the antidepressant fluoxetine
Mueller, Juliane C.
Imazaki, Pedro H.
Boareto, Ana C.
Lourenco, Emerson L. B.
Golin, Munisa
Vechi, Marina F.
Lombardi, Natalia F.
Minatovicz, Bruna C.
Scippo, Marie-Louise
Martino-Andrade, Anderson J.
Dalsenter, Paulo R.
REPRODUCTIVE TOXICOLOGY, 2012, 34 (01) : 80 - 85
[39] Fluoxetine dose and outcome in antidepressant drug trials
Barbui, C
Hotopf, M
Garattini, S
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (06) : 379 - 386
[40] Sleep deprivation hastens the antidepressant action of fluoxetine
F. Benedetti
B. Barbini
A. Lucca
E. Campori
C. Colombo
E. Smeraldi
European Archives of Psychiatry and Clinical Neuroscience, 1997, 247 : 100 - 103

← 1 2 3 4 5 →